
Veta Genomics Private Limited
About Veta Genomics Private Limited
Data last updated:
Veta Genomics Private Limited is a private limited company based in Thrissur, Kerala, India, recognised as a startup by DPIIT. It operates in the healthcare services segment of the healthcare sector. It was incorporated on 23 June 2022.
The company is registered with the Registrar of Companies (ROC), Ernakulam, under CIN U85100KL2022PTC076344.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors including Neduveliparambil Murugan Praveen (Managing Director) and Hridya.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Anna Tower First Floor Bldg No. 7/55 Pallimoola Engineering College Po, Thrissur, Kerala, India – 680009.
As per the financials filed for FY 2024, the company reported a revenue of ₹43.36 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹26.51 Lakh (net margin -61.1%) and EBITDA of -₹20.34 Lakh (EBITDA margin -46.9%).
As per MCA filings, the company has open charges of ₹61 Lakh on record.
Veta Genomics Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-KL-13-0031597).
Company details
Recognitions & Rankings of Veta Genomics
- Category
- Micro (2022-23)
- Udyam number
- UDYAM-KL-13-0031597
Contact details
Veta Genomics Private Limited's registered office is in Thrissur, Kerala.
- Registered AddressAnna Tower First Floor Bldg No. 7/55 Pallimoola Engineering College Po, Thrissur, Kerala, India – 680009
- IndustryHealthcare, Human Health Activities
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Veta Genomics is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities |
To see the full business activity and turnover split of Veta Genomics Private Limited, buy the company report.
Financials of Veta Genomics Private Limited
FY 2025 filings availableVeta Genomics Private Limited reported revenue of ₹43.36 Lakh (up 260% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue rose 260% in the latest year. EBITDA rose 6% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | -₹20.34 Lakh | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | -₹26.51 Lakh | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | -46.9% | |
| Net Profit Margin | -61.1% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Veta Genomics Private Limited, buy the company report.
Board of directors of Veta Genomics Private Limited
Veta Genomics has 4 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Hridya | Director | 23 Jun 2022 | 4 Years 4 Months | Current |
| Neduveliparambil Murugan Praveen Also directs: Hygea Med Laboratories LLP | Managing Director | 23 Jun 2022 | 4 Years 4 Months | Current |
| Manoj Kumar Also directs: Hygea Med Laboratories LLP | Director | 19 Dec 2022 | 3 Years 10 Months | Current |
| Shaju Thuppinikkattu Kunjalan Also directs: Hygea Med Laboratories LLP | Director | 10 Nov 2022 | 3 Years 11 Months | Current |
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 18 Aug 2025 | 101154019 | Idbi Bank Limited | ₹46 Lakh | Open | |
| 22 Nov 2024 | 101030640 | Idbi Bank Limited | ₹15 Lakh | Open |
To see the full charge records of Veta Genomics Private Limited, buy the company report.
Total charge records: 2 View all charges
Legal cases
No court or tribunal cases involving Veta Genomics Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Veta Genomics Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Veta Genomics Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Veta Genomics Private Limited has 6 board changes on record since 2022: 4 appointments and 2 cessations. The latest: Manoj Kumar ceased to be Additional Director on 30 Dec 2023.
Frequently asked questions
Veta Genomics is an active private limited company based in Thrissur, Kerala, India. The company works in human health activities, within the healthcare industry. It was incorporated on 23 June 2022 (4+ years old) and is registered under CIN U85100KL2022PTC076344.
Veta Genomics has 4 current directors:
- Neduveliparambil Murugan Praveen - Managing Director
- Hridya - Director
- Manoj Kumar - Director
- Shaju Thuppinikkattu Kunjalan - Director
The latest financial statements of Veta Genomics on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.
The CIN (Corporate Identification Number) of Veta Genomics is U85100KL2022PTC076344. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Veta Genomics was incorporated on 23 June 2022, making it 4+ years old. It is registered with the Registrar of Companies, Ernakulam.
Manoj Kumar ceased to be Additional Director on 30 Dec 2023. Shaju Thuppinikkattu Kunjalan ceased to be Additional Director on 30 Dec 2023. Manoj Kumar was appointed as Director on 19 Dec 2022. Veta Genomics has 6 board changes on record in total.
Yes, Veta Genomics is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Yes, Veta Genomics is registered as a micro enterprise under Udyam registration (number: UDYAM-KL-13-0031597).
The registered office of Veta Genomics is at Anna Tower First Floor Bldg No. 755 Pallimoola Engineering College Po, Thrissur, Kerala, India – 680009.
Veta Genomics operates in the healthcare industry, in the human health activities segment.